Close Menu

NEW YORK (360Dx) – said recently that it has raised $18 million in Series B funding to help scale up an at-home testing service that uses its US Food and Drug Administration-cleared smartphone urinalysis test kit for detecting kidney disease.

The funding round was led by Aleph with "significant contributions" from Samsung Next and other private investors, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.